Alex Garcia

Alex Garcia currently serves as the Growth and Emerging Markets Vaccines Franchise Head at Takeda, where responsibilities include leading the US Travel Vaccines Franchise and overseeing the commercialization of Takeda's dengue vaccine. Previously, Alex held significant roles at GSK, Novartis Vaccines and Diagnostics, Abbott Laboratories, and other organizations, with a focus on driving revenue growth and managing global vaccination portfolios. Academic qualifications include an MBA from The Wharton School and a B.Sc. in Microbiology & Immunology from McGill University. Alex's career has been marked by impactful product launches and strategic marketing initiatives in the pharmaceutical and healthcare sectors.